p53 induces distinct epigenetic states at its direct target promoters

January 2008
BMC Genomics;2008 Supplement 2, Vol. 9, p486
Academic Journal
No abstract available.


Related Articles

  • Targeted p16Ink4a epimutation causes tumorigenesis and reduces survival in mice. Da-Hai Yu; Waterland, Robert A.; Pumin Zhang; Schady, Deborah; Miao-Hsueh Chen; Yongtao Guan; Gadkari, Manasi; Lanlan Shen // Journal of Clinical Investigation;Sep2014, Vol. 124 Issue 9, p3708 

    Cancer has long been viewed as a genetic disease; however, epigenetic silencing as the result of aberrant promoter DNA methylation is frequently associated with cancer development, suggesting an epigenetic component to the disease. Nonetheless, it has remained unclear whether an epimutation (an...

  • Epigenetic targets in hematopoietic malignancies. Claus, Rainer; Lübbert, Michael // Oncogene;9/29/2003 Review, Vol. 22 Issue 42, p6489 

    Frequent genetic alterations in hematopoietic neoplasias (chromosomal translocations, point mutations, etc.) have provided biologic targets for the development of effective novel therapies. A rapidly increasing body of knowledge provides evidence also for multiple epigenetic alterations in these...

  • Bidirectional Transcription Directs Both Transcriptional Gene Activation and Suppression in Human Cells. Morris, Kevin V.; Santoso, Sharon; Turner, Anne-Marie; Pastori, Chiara; Hawkins, Peter G. // PLoS Genetics;Nov2008, Vol. 4 Issue 11, p1 

    Small RNAs targeted to gene promoters in human cells have been shown to modulate both transcriptional gene suppression and activation. However, the mechanism involved in transcriptional activation has remained poorly defined, and an endogenous RNA trigger for transcriptional gene silencing has...

  • Histone demethylase Jumonji D3 (JMJD3/KDM6B) at the nexus of epigenetic regulation of inflammation and the aging process. Salminen, Antero; Kaarniranta, Kai; Hiltunen, Mikko; Kauppinen, Anu // Journal of Molecular Medicine;Oct2014, Vol. 92 Issue 10, p1035 

    Histone methylation is involved in the epigenetic control of immune responses and cellular senescence. Jumonji domain-containing protein 3 (JMJD3), also called lysine-specific demethylase 6B (KDM6b), is an inducible histone demethylase which enhances immune responses and can trigger cellular...

  • Inhibiting Enhancer of Zeste Homolog 2 Promotes Cellular Senescence in Gastric Cancer Cells SGC-7901 by Activation of p21 and p16. Bai, Jie; Chen, Junhua; Ma, Muyuan; Cai, Ming; Xu, Fei; Wang, Guobin; Tao, Kaixiong; Shuai, Xiaoming // DNA & Cell Biology;Jun2014, Vol. 33 Issue 6, p337 

    Cellular senescence, which can be defined as a stress response preventing the propagation of cells that have accumulated potentially oncogenic alterations, is invariably associated with a permanent cell cycle arrest. Enhancer of zeste homolog 2 (EZH2) as a member of polycomb group proteins and...

  • Epigenetic Mechanism Involved in the HBV/HCV-Related Hepatocellular Carcinoma Tumorigenesis. Rongrui, Liang; Na, Huang; Zongfang, Li; Fanpu, Ji; Shiwen, Jiang // Current Pharmaceutical Design;Apr2014, Vol. 20 Issue 11, p1715 

    Hepatitis B virus (HBV) and hepatitis C virus (HCV) infection were known to be risk factors for HCC, they were suspected to promote its development by eliciting epigenetic changes. However, the precise gene targets and underlying mechanisms have not been elucidated. Epigenetic regulation of gene...

  • Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression. Narayan, Gopeshwar; Goparaju, Chandra; Arias-Pulido, Hugo; Kaufmann, Andreas M.; Schneider, Achim; Dürst, Matthias; Mansukhani, Mahesh; Pothuri, Bhavana; Murty, Vundavalli V. // Molecular Cancer;2006, Vol. 5, p16 

    Background: Cervical Cancer (CC) exhibits highly complex genomic alterations. These include hemizygous deletions at 4p15.3, 10q24, 5q35, 3p12.3, and 11q24, the chromosomal sites of Slit-Robo pathway genes. However, no candidate tumor suppressor genes at these regions have been identified so far....

  • Epigenetic Alteration by DNA Promoter Hypermethylation of Genes Related to Transforming Growth Factor-β (TGF-β) Signaling in Cancer. Khin, Sann Sanda; Kitazawa, Riko; Kondo, Takeshi; Idei, Yuka; Fujimoto, Masayo; Haraguchi, Ryuma; Mori, Kiyoshi; Kitazawa, Sohei // Cancers;2011, Vol. 3 Issue 1, p982 

    Epigenetic alterations in cancer, especially DNA methylation and histone modification, exert a significant effect on the deregulated expression of cancer-related genes and lay an epigenetic pathway to carcinogenesis and tumor progression. Global hypomethylation and local hypermethylation of CpG...

  • MK3 controls Polycomb target gene expression via negative feedback on ERK. Prickaerts, Peggy; Niessen, Hanneke E.C.; Mouchel-Vielh, Emmanuèle; Dahlmans, Vivian E.H.; van den Akker, Guus G.H.; Geijselaers, Claudia; Adriaens, Michiel E.; Spaapen, Frank; Yoshihiro Takihara; Rapp, Ulf R.; Peronnet, Frédérique; Willem Voncken, Jan // Epigenetics & Chromatin;2012, Vol. 5 Issue 1, p12 

    Background: Gene-environment interactions are mediated by epigenetic mechanisms. Polycomb Group proteins constitute part of an epigenetic cellular transcriptional memory system that is subject to dynamic modulation during differentiation. Molecular insight in processes that control dynamic...

  • Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosis. Dreidax, Daniel; Gogolin, Sina; Schroeder, Christina; Muth, Daniel; Brueckner, Lena Marie; Hess, Elisa Maria; Zapatka, Marc; Theißen, Jessica; Fischer, Matthias; Ehemann, Volker; Schwab, Manfred; Savelyeva, Larissa; Westermann, Frank // Human Molecular Genetics;May2013, Vol. 22 Issue 9, p1735 

    The TP53 tumor suppressor pathway is abrogated by TP53 mutations in the majority of human cancers. Increased levels of wild-type TP53 in aggressive neuroblastomas appear paradox but are tolerated by tumor cells due to co-activation of the TP53 ubiquitin ligase, MDM2. The role of the MDM2...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics